Stocks and Investing
Stocks and Investing
Mon, January 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (CELU) at Strong Buy with Decreased Target to $25 on, Jan 30th, 2023
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Celularity Inc." (CELU) at Strong Buy with Decreased Target from $150 to $25 on, Jan 30th, 2023.
Swayampakula has made no other calls on CELU in the last 4 months.
There is 1 other peer that has a rating on CELU. Out of the 1 peers that are also analyzing CELU, all agrees with Swayampakula's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Biegler of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, December 22nd, 2022
Contributing Sources